Limbic Encephalitis With Lgi1 Antibodies clinical trials

Explore recruiting limbic encephalitis with lgi1 antibodies clinical trials.

Recruiting limbic encephalitis with lgi1 antibodies studies right now

Study details & eligibility ClinicalTrials.gov record

Limbic Encephalitis With Lgi1 Antibodies trials by city

Limbic Encephalitis With Lgi1 Antibodies in Toronto Limbic Encephalitis With Lgi1 Antibodies in Vancouver Limbic Encephalitis With Lgi1 Antibodies in Montreal Limbic Encephalitis With Lgi1 Antibodies in Calgary Limbic Encephalitis With Lgi1 Antibodies in Edmonton Limbic Encephalitis With Lgi1 Antibodies in Ottawa Limbic Encephalitis With Lgi1 Antibodies in Winnipeg Limbic Encephalitis With Lgi1 Antibodies in Quebec City Limbic Encephalitis With Lgi1 Antibodies in Hamilton Limbic Encephalitis With Lgi1 Antibodies in Kitchener Limbic Encephalitis With Lgi1 Antibodies in London Limbic Encephalitis With Lgi1 Antibodies in Halifax Limbic Encephalitis With Lgi1 Antibodies in New York Limbic Encephalitis With Lgi1 Antibodies in Los Angeles Limbic Encephalitis With Lgi1 Antibodies in Chicago Limbic Encephalitis With Lgi1 Antibodies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease